| 1 |
Majno G．The ancient riddle of sigma eta psi iota sigma (sepsis)[J]．J Infect Dis，1991，163(5):937-945.
|
| 2 |
Bone RC, Sibbald WJ, Sprung CL.The ACCP-SCCM consensus conference on sepsis and organ failure[J]．Chest，1992，101(6):1481-1483.
|
| 3 |
Hotchkiss RS, Moldawer LL, Opal SM，et al.Sepsis and septic shock[J]．Nat Rev Dis Primers, 2016，2:16045.
|
| 4 |
Machado JR, Soave DF, da Silva MV，et al.Neonatal sepsis and inflammatory mediators[J]．Mediators Inflamm，2014，2014:269681.
|
| 5 |
Accardo Palumbo A, Forte GI, Pileri D，et al.Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients[J]．Burns，2012，38(2):208-213.
|
| 6 |
Sugitharini V, Prema A, Berla Thangam E．Inflammatory mediators of systemic inflammation in neonatal sepsis[J]．Inflamm Res，2013，62(12):1025-1034.
|
| 7 |
Thijs LG, Hack CE.Time course of cytokine levels in sepsis[J]．Intensive Care Med，1995，21 Suppl 2:S258-S263.
|
| 8 |
Baernthsen NF, Hansen MB, Wahl AM，et al.Treatment with 24 h-delayed normo- and hyperbaric oxygenation in severe sepsis induced by cecal ligation and puncture in rats[J]．J Inflamm(Lond)，2017，14:27.
|
| 9 |
Mosevoll KA, Skrede S, Markussen DL，et al.Inflammatory mediator profiles differ in sepsis patients with and without bacteremia[J]．Front Immunol，2018，9:691.
|
| 10 |
Bingold TM, Ziesche E, Scheller B，et al.Interleukin-22 detected in patients with abdominal sepsis[J]．Shock，2010，34(4):337-340.
|
| 11 |
Rendon JL, Choudhry MA.Th17 cells: critical mediators of host responses to burn injury and sepsis[J]．J Leukoc Biol，2012，92(3):529-538.
|
| 12 |
Weber GF, Schlautkotter S, Kaiser-Moore S，et al.Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis[J]．Infect Immun，2007，75(4):1690-1697.
|
| 13 |
Joshi A, Pancari G, Cope L，et al.Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model[J]．Hum Vaccin Immunother，2012，8(3):336-346.
|
| 14 |
Takeuchi O, Akira S．Pattern recognition receptors and inflammation[J]．Cell，2010，140(6):805-820.
|
| 15 |
Cohen J．The immunopathogenesis of sepsis[J]．Nature，2002，420(6917):885-891.
|
| 16 |
Perusina Lanfranca M, Lin Y, Fang J，et al.Biological and pathological activities of interleukin-22[J]．J Mol Med(Berl)，2016，94(5):523-534.
|
| 17 |
Xu Y, Wang H, Bao S，et al.Amelioration of liver injury by continuously targeted intervention against TNFRp55 in rats with acute-on-chronic liver failure[J]．PLoS One，2013，8(7):e68757.
|
| 18 |
熊亮，向菲，周琼，等．结核分枝杆菌感染环境中不同细胞因子对胸膜间皮细胞增殖和凋亡的影响[J]．中华结核和呼吸杂志，2013，36(5):341-345.
|
| 19 |
Wen Z, Liao Q, Zhao J，et al.High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma[J]．Ann Surg Oncol，2014，21(1):125-132.
|
| 20 |
Abdalla AE, Lambert N, Duan X，et al.Interleukin-10 Family and Tuberculosis：An Old Story Renewed[J]．Int J Biol Sci，2016，12(6):710-717.
|
| 21 |
Smith CL, Arvedson TL, Cooke KS，et al.IL-22 regulates iron availability in vivo through the induction of hepcidin[J]．J Immunol，2013，191(4):1845-1855.
|
| 22 |
Zhang S, Fujita H, Mitsui H，et al.Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma[J]．PLoS One，2013，8(5):e62154.
|
| 23 |
Yang X, Zheng SG.Interleukin-22：a likely target for treatment of autoimmune diseases[J]．Autoimmun Rev，2014，13(6):615-620.
|
| 24 |
Weathington NM, Snavely CA, Chen BB，et al.Glycogen synthase kinase-3beta stabilizes the interleukin (IL)-22 receptor from proteasomal degradation in murine lung epithelia[J]．J Biol Chem，2014，289(25):17610-17619.
|
| 25 |
Liu DJ, Liu Y, Ran LM，et al.Genetic variants in interleukin genes and susceptibility to IgA nephropathy: a meta-analysis[J]．DNA Cell Biol，2014，33(6):345-354.
|
| 26 |
Pérez-Cordón G, Estensoro I, Benedito-Palos L，et al.Interleukin gene expression is strongly modulated at the local level in a fish-parasite model[J]．Fish Shellfish Immunol，2014，37(2):201-208.
|
| 27 |
Dash R, Bhoopathi P, Das SK，et al.Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction[J]．Cancer Res，2014，74(2):563-574.
|
| 28 |
Donnelly RP, Sheikh F, Kotenko SV，et al.The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain[J]．J Leukoc Biol，2004，76(2):314-321.
|
| 29 |
Commins S, Steinke JW, Borish L．The extended IL-10 superfamily：IL-10，IL-19，IL-20，IL-22，IL-24，IL-26，IL-28，and IL-29[J]．J Allergy Clin Immunol，2008，121(5):1108-1111.
|
| 30 |
Fickenscher H, Hor S, Kupers H，et al.The interleukin-10 family of cytokines[J]．Trends Immunol，2002，23(2):89-96.
|
| 31 |
Conti P, Kempuraj D, Frydas S，et al.IL-10 subfamily members: IL-19，IL-20，IL-22，IL-24 and IL-26[J]．Immunol Lett，2003，88(3):171-174.
|
| 32 |
Pestka S, Krause CD, Sarkar D，et al.Interleukin-10 and related cytokines and receptors[J]．Annu Rev Immunol，2004，22:929-979.
|
| 33 |
Kotenko SV.The family of IL-10-related cytokines and their receptors: related, but to what extent？[J]．Cytokine Growth Factor Rev，2002，13(3):223-240.
|
| 34 |
Nagalakshmi ML, Murphy E, McClanahan T，et al.Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization[J]．Int Immunopharmacol，2004, 4(5):577-592.
|
| 35 |
Ouyang W, Rutz S, Crellin NK，et al.Regulation and functions of the IL-10 family of cytokines in inflammation and disease[J]．Annu Rev Immunol，2011，29:71-109.
|
| 36 |
Berg DJ, Kühn R, Rajewsky K，et al.Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance[J]．J Clin Invest，1995，96(5):2339-2347.
|
| 37 |
Kato T, Murata A, Ishida H，et al.Interleukin 10 reduces mortality from severe peritonitis in mice[J]. Antimicrob Agents Chemother，1995，39(6):1336-1340.
|
| 38 |
Howard M, Muchamuel T, Andrade S，et al.Interleukin 10 protects mice from lethal endotoxemia[J]．J Exp Med，1993，177(4):1205-1208.
|
| 39 |
Sabat R, Ouyang W, Wolk K．Therapeutic opportunities of the IL-22-IL-22R1 system[J]. Nat Rev Drug Discov，2014，13(1):21-38.
|
| 40 |
Fabbrini E, Cella M, McCartney SA，et al.Association between specific adipose tissue CD4＋ T-cell populations and insulin resistance in obese individuals[J]．Gastroenterology，2013，145(2):366-374 e361-363.
|
| 41 |
Dalmas E, Venteclef N, Caer C，et al.T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes[J]．Diabetes，2014，63(6):1966-77.
|
| 42 |
Cordero-Coma M, Calleja S, Llorente M，et al.Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responses[J]．Ocul Immunol Inflamm, 2013, 21(3):212-219.
|
| 43 |
Sonnenberg GF, Fouser LA, Artis D．Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22[J]．Nat Immunol，2011，12(5):383-390.
|
| 44 |
Witte E, Witte K, Warszawska K，et al.Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection[J]．Cytokine Growth Factor Rev，2010，21(5):365-379.
|
| 45 |
Kong Q, Xue Y, Wu W，et al.IL-22 exacerbates the severity of CVB3-induced acute viral myocarditis in IL-17A-deficient mice[J]．Mol Med Rep，2013，7(4):1329-1335.
|
| 46 |
Sugita S, Kawazoe Y, Imai A，et al.Role of IL-22-and TNF-alpha-producing Th22 cells in uveitis patients with Behcet’s disease[J]．J Immunol，2013，190(11):5799-5808.
|
| 47 |
Sugita S, Kawazoe Y, Imai A，et al.Suppression of IL-22-producing T helper 22 cells by RPE cells via PD-L1/PD-1 interactions[J]．Invest Ophthalmol Vis Sci，2013，54(10):6926-6933.
|
| 48 |
Zaidi T, Zaidi T, Cywes-Bentley C，et al.Microbiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye[J]．Infect Immun，2014，82(8):3483-3491.
|
| 49 |
Dudakov JA, Hanash AM, Jenq RR，et al.Interleukin-22 drives endogenous thymic regeneration in mice[J]．Science，2012，336(6077):91-95.
|
| 50 |
Andoh A, Zhang Z, Inatomi O，et al.Interleukin-22，a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts[J]．Gastroenterology, 2005, 129(3):969-984.
|
| 51 |
Muhl H．Pro-Inflammatory Signaling by IL-10 and IL-22：Bad Habit Stirred Up by Interferons？[J]．Front Immunol，2013，4:18.
|
| 52 |
Ziesche E, Scheiermann P, Bachmann M，et al.Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo[J]．Clin Exp Immunol，2009，157(3):370-376.
|
| 53 |
重庆市中西医结合学会灾害医学专业委员会，中国研究型医院学会卫生应急学专业委员会，中国中西医结合学会灾害医学专业委员会．创伤后免疫功能紊乱临床逆转措施专家共识(2018)[J/CD]．中华卫生应急电子杂志，2018, 4(2): 65-71.
|